Nevertheless, the detection of this expression in the malignant cells of DLBCL of the palatine tonsils indicates the potential role of RCAS1 protein in the phenomenon of selective immune suppression and the creation of tumor-induced chronic inflammation in this disease, as in other malignant diseases. The gene discussed is EBAG9; the disease is neoplasm.